drug
nevirapine
Marketedupdated 6mo agoby Camber Pharmaceuticals Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying nevirapine
Patent cliff
source: FDA Orange Bookfirst barrier falls
Mar 12, 2029
~2.3 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (1)
- Mar 12, 2029method-of-use (U-1409)US 84607042.3y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that